# VIEKIRA XR
> **NDA208624** · New Drug Application · Sponsor: ABBVIE · Approved 2016-07-22
## Drug
- **FDA Application Number:** NDA208624
- **Application type:** New Drug Application
- **Brand name:** VIEKIRA XR
- **Generic name:** Dasabuvir Sodium
- **Active ingredients:** DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ABBVIE
- **First approval:** 2016-07-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208624)
---
*AI Analytics · CC0 1.0*